Popular weight-loss drug may leave stomach full despite fasting, study warns
NCT ID NCT07398222
First seen Feb 10, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study uses ultrasound to check if people taking tirzepatide (a weight-loss and diabetes drug) still have food or liquid in their stomach after the recommended fasting period. A full stomach during anesthesia can lead to serious complications. The study compares 30 adults who take tirzepatide with those who do not, all after fasting, to see how often a full stomach occurs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FULL STOMACH STATUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Israelita Albert Einstein
RECRUITINGSão Paulo, São Paulo, 05652900, Brazil
Conditions
Explore the condition pages connected to this study.